As of early May 2026, the CDC has confirmed 1,842 measles cases in the United States, on pace to exceed 2025’s full-year total of 2,288, with 93% tied to ongoing outbreaks across 36 states. This resurgence stems from sustained declines in MMR vaccination coverage, leaving clusters of unvaccinated children and adolescents vulnerable to highly transmissible airborne spread from imported cases. Official data show 72% of 2026 infections occurring in those under 20, with most linked to domestic outbreaks rather than travel alone. Weekly CDC surveillance updates on new case counts, outbreak expansions, and vaccination status distributions will continue to shape trader assessments of whether the year-end total surpasses or falls short of recent highs.
Eksperymentalne podsumowanie AI odwołujące się do danych Polymarket. To nie jest porada handlowa i nie ma wpływu na rozstrzyganie tego rynku. · ZaktualizowanoPrzypadki odry w USA w 2026 roku?
Przypadki odry w USA w 2026 roku?
$7,669,925 Wol.
$7,669,925 Wol.
Dec 31, 2026
↑2k
99%
↑3k
62%
↑4k
28%
↑5k
14%
↑7,5 tys.
14%
↑10k
10%
↑12,5 tys.
5%
$7,669,925 Wol.
$7,669,925 Wol.
Dec 31, 2026
↑2k
$45,436 Wol.
99%
↑3k
$50,414 Wol.
62%
↑4k
$170,864 Wol.
28%
↑5k
$215,382 Wol.
14%
↑7,5 tys.
$174,338 Wol.
14%
↑10k
$6,493,892 Wol.
10%
↑12,5 tys.
$344,846 Wol.
5%
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.As of early May 2026, the CDC has confirmed 1,842 measles cases in the United States, on pace to exceed 2025’s full-year total of 2,288, with 93% tied to ongoing outbreaks across 36 states. This resurgence stems from sustained declines in MMR vaccination coverage, leaving clusters of unvaccinated children and adolescents vulnerable to highly transmissible airborne spread from imported cases. Official data show 72% of 2026 infections occurring in those under 20, with most linked to domestic outbreaks rather than travel alone. Weekly CDC surveillance updates on new case counts, outbreak expansions, and vaccination status distributions will continue to shape trader assessments of whether the year-end total surpasses or falls short of recent highs.
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
Rynek otwarty: Feb 16, 2026, 11:51 AM ET
Wolumen
$7,669,925Data zakończenia
Dec 31, 2026Rynek otwarty
Feb 16, 2026, 11:51 AM ETResolver
0x65070BE91...This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.As of early May 2026, the CDC has confirmed 1,842 measles cases in the United States, on pace to exceed 2025’s full-year total of 2,288, with 93% tied to ongoing outbreaks across 36 states. This resurgence stems from sustained declines in MMR vaccination coverage, leaving clusters of unvaccinated children and adolescents vulnerable to highly transmissible airborne spread from imported cases. Official data show 72% of 2026 infections occurring in those under 20, with most linked to domestic outbreaks rather than travel alone. Weekly CDC surveillance updates on new case counts, outbreak expansions, and vaccination status distributions will continue to shape trader assessments of whether the year-end total surpasses or falls short of recent highs.
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
Wolumen
$7,669,925Data zakończenia
Dec 31, 2026Rynek otwarty
Feb 16, 2026, 11:51 AM ETResolver
0x65070BE91...As of early May 2026, the CDC has confirmed 1,842 measles cases in the United States, on pace to exceed 2025’s full-year total of 2,288, with 93% tied to ongoing outbreaks across 36 states. This resurgence stems from sustained declines in MMR vaccination coverage, leaving clusters of unvaccinated children and adolescents vulnerable to highly transmissible airborne spread from imported cases. Official data show 72% of 2026 infections occurring in those under 20, with most linked to domestic outbreaks rather than travel alone. Weekly CDC surveillance updates on new case counts, outbreak expansions, and vaccination status distributions will continue to shape trader assessments of whether the year-end total surpasses or falls short of recent highs.
Eksperymentalne podsumowanie AI odwołujące się do danych Polymarket. To nie jest porada handlowa i nie ma wpływu na rozstrzyganie tego rynku. · Zaktualizowano
Uważaj na linki zewnętrzne.
Uważaj na linki zewnętrzne.
Często zadawane pytania